Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen, Mayo Clinic Parkinson s Disease Collaboration Awarded Grant

NEW YORK, June 14 (GenomeWeb News) - Perlegen Life Sciences and the Mayo Clinic said today that their collaboration on a whole genome association study of Parkinson's disease has been awarded a grant worth up to $2.8 million by the Michael J. Fox Foundation for Parkinson's Research.

 

Under the partnership, the collaborators are combining Perlegen's high-throughput genotyping technology and genetic variation know-how with the Mayo Clinic's DNA samples from Parkinson's disease patients in order to look for single nucleotide polymorphisms believed to be associated with the disorder. The effort is expected to yield 200 million genotypes, which will be validated in a separate population of Mayo Clinic DNA samples so that Parkinson's disease SNPs can be identified.

 

 

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.